The application provides a preparation method of
paeonol glycoside for inhibiting GM-CSF + The application belongs to the technical field of biological
medicine, and relates to application of Th
cell differentiation in a
medicine for preventing and / or treating
rheumatoid arthritis (RA). + Abnormal activation of Th cells is obviously earlier than appearance of clinical symptoms of RA in a time axis, is an early key initiating factor for driving occurrence of the RA
disease, and is a core target point for implementing an early blocking strategy. + Further, it is found that
paeonol glycoside (Alb) can block a gamma c / JAK3 / STAT5
signal path by targeting and combining with an
interleukin-2
receptor gamma chain, down-regulate CSF2
gene transcription and GM-CSF
protein expression, thereby inhibiting differentiation of Th cells, and finally achieving an effect of preventing occurrence of CIA
arthritis and not rebounding after
drug withdrawal. The application provides a new intervention
medicine which is high in safety, suitable for long-term use, can effectively regulate immune abnormalities in a pre-RA stage, prevents
rheumatoid arthritis, and has a wide application prospect.